Related Experiment Videos
Persisting epithelial herpes simplex keratitis while on cyclosporin-A ointment.
1Ridley Eye Clinic, Box 539, Manunda, Cairns 4870, Queensland.
Australian and New Zealand Journal of Ophthalmology
|November 1, 1995
Summary
Cyclosporin-A (CsA) ointment can worsen herpes simplex virus (HSV) keratitis in corneal grafts. Stopping CsA treatment led to the resolution of epithelial HSV keratitis, indicating CsA
Area of Science:
- Ophthalmology
- Immunology
Background:
- Reports the first known adverse effect of cyclosporin-A (CsA) ointment on epithelial herpes simplex virus (HSV) keratitis in a corneal graft recipient.
- Highlights a potential complication in post-keratoplasty care.
Observation:
- A patient receiving CsA ointment developed epithelial HSV keratitis.
- The condition persisted despite standard topical treatments.
Findings:
- Discontinuation of CsA ointment led to the successful resolution of epithelial HSV keratitis.
- This suggests CsA-induced immunosuppression contributed to the persistent viral infection.
Implications:
- Clinicians should consider the potential for CsA to exacerbate HSV keratitis in corneal grafts.
- Careful monitoring and potential adjustment of immunosuppressive therapy may be necessary for patients with a history of HSV.